The discovery of PD-1—a receptor expressed on activated T cells and its ligand PD-L1, expressed on tumor cells – identified another immunosuppressive mechanism that inactivates TCR and/or CD28 signaling, thereby impairing the normal function of cytotoxic effector T cells (Teff). This evidence concerns the gene PDCD1 and neoplasm.